Fangsheng pharmaceutical continued to increase the promotion of new drug research and development in 2015
-
Last Update: 2020-04-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
"New drug research and development has always been our core advantage At present, our new anti-cancer drugs have reached the stage of expert review It is estimated that in three or five months, there will be expert opinions, or enter the clinical stage, or we will be required to supplement the materials Now we have applied for patents in 20 or 30 countries for this new drug " At the 2014 annual general meeting of shareholders held on March 30, Zhang Qinghua, chairman of Fangsheng pharmaceutical, disclosed According to the 2014 annual report of Fangsheng pharmaceutical, the operating revenue is about 415610000 yuan, the net profit attributable to the shareholders of the listed company is about 80.99 million yuan, and the earnings per share is 0.96 yuan, up 3.84%, 10.29% and 0.81% year on year respectively The chairman of the board of directors of the company proposes to distribute cash dividends of 0.12 yuan (including tax) per share and bonus shares of 3 shares (including tax) per 10 shares It is understood that in 2014, the company increased its investment in scientific research, actively introduced high-end talents, expanded its R & D team, and strengthened the R & D promotion of various new drugs In 2015, the company will continue to increase its efforts in scientific research and new products, and the completion and operation of its new plant will contribute to the improvement of the company's profitability.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
